An In Vitro Investigation of the Effects of Periostin on Osteoblastic Adhesion and Proliferation on Collagen Matrices

Main Article Content

Pragyan Swain
Ranishree Behera
Saswati Mohanty
Anindita Ghosh
Bhumika J. Patel
Kapil Paiwal


Purpose:The goal of the research was to determine how osteoblast cell adhesion, proliferation, and activity were affected when periostin was impregnated into various collagen matrices.

Materials and Methods:Onto two distinct collagen matrices, These are the steps used to cultivate and seed Saos-2 osteoblast cells: “Absorbable collagen sponges (ACS) are in Group A, absorbable collagen sponges impregnated with human periostin recombinant are in Group B, nanocrystalline hydroxyapatite collagen (NcHC) is in Group C, and NcHC impregnated with human periostin recombinant is in Group D. A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide test was performed on days 2, 5, and 7 to evaluate cell viability, adhesion, and proliferation.” Alkaline phosphatase (ALP) test was used to examine osteoblast activity in the research groups.

Results:On days 2, 5, and 7 the osteoblast adhesion in the periostin-treated absorbable collagen matrices was statistically significantly higher than that in the untreated NcHC (P=0.001). According to the results of the ALP test, the osteoblast activity in the periostin-treated ACS was higher than that in the periostin-treated NcHC.


It is clear from the results of this research that Periostin plays a substantial part in regulating the cellular response of the osteoblast cells. Moreover, it has been shown that adding periostin to the ACS improves the osteoblast-like Saos-2 cells' cell survival, proliferation, and adhesion.

Article Details

How to Cite
Swain, P. ., Behera, R. ., Mohanty, S. ., Shanvi, Ghosh , A. ., J. Patel, B. ., & Paiwal , K. . (2023). An In Vitro Investigation of the Effects of Periostin on Osteoblastic Adhesion and Proliferation on Collagen Matrices. Journal of Coastal Life Medicine, 11(1), 1345–1352. Retrieved from


Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta. J Bone Miner Res. 1999;14:1239–49.

Suzuki H, Amizuka N, Kii I, Kawano Y, Nozawa-Inoue K, Suzuki A, et al. Immunohistochemical localization of periostin in tooth and its surrounding tissues in mouse mandibles during development. Anat Rec A Discov Mol Cell Evol Biol. 2004;281:1264–75.

Merle B, Garnero P. The multiple facets of periostin in bone metabolism. Osteoporos Int. 2012;23:1199–212.

Shimazaki M, Nakamura K, Kii I, Kashima T, Amizuka N, Li M, et al. Periostin is essential for cardiac healing after acute myocardial infarction. J Exp Med. 2008;205:295–303.

Ouyang G, Liu M, Ruan K, Song G, Mao Y, Bao S. Upregulated expression of periostin by hypoxia in non-small-cell lung cancer cells promotes cell survival via the Akt/PKB Pathway. Cancer Let. 2009;281:213–9.

Kühn B, del Monte F, Hajjar RJ, Chang YS, Lebeche D, Arab S, et al. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. Nat Med. 2007;13:962–9.

Zhao M, Xiao G, Berry JE, Franceschi RT, Reddi A, Somerman MJ. Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype. J Bone Miner Res. 2002;17:1441–51.

Ahn SH, Kim CS, Suk HJ, Lee YJ, Choi SH, Chai JK, et al. Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects. J Periodontol. 2003;74:787–97.

Jin QM, Zhao M, Economides AN, Somerman MJ, Giannobile WV. Noggin gene delivery inhibits cementoblast-induced mineralization. Connect Tissue Res. 2004;45:50–9.

Lyngstadaas SP, Lundberg E, Ekdahl H, Andersson C, Gestrelius S. Autocrine growth factors in human periodontal ligament cells cultured on enamel matrix derivative. J Clin Periodontol. 2001;28:181–8.

Padial-Molina M, Volk SL, Rios HF. Periostin increases migration and proliferation of human periodontal ligament fibroblasts challenged by tumor necrosis factor -α and Porphyromonas gingivalis lipopolysaccharides. J Periodontal Res. 2014;49:405–14.

Heo SC, Shin WC, Lee MJ, Kim BR, Jang IH, Choi EJ, et al. Periostin accelerates bone healing mediated by human mesenchymal stem cell-embedded hydroxyapatite/tricalcium phosphate scaffold. PLoS One. 2015;10 doi:10.1371/journal.pone.0116698:1-17. 13. Zhu S, Barbe MF, Liu C, Hadjiargyrou M, Popoff SN, Rani S, et al. Periostin-like-factor in osteogenesis. J Cell Physiol. 2009;218:584–92.

Rani S, Barbe MF, Barr AE, Litivn J. Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping. J Cell Physiol. 2010;225:152–67.

Wang HL, Miyauchi M, Takata T. Initial attachment of osteoblasts to various guided bone regeneration membranes: An in vitro study. J Periodontal Res. 2002;37:340–4.

Geiger M, Li RH, Friess W. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev. 2003;55:1613–29.

Matsuno T, Nakamura T, Kuremoto K, Notazawa S, Nakahara T, Hashimoto Y, et al. Development of beta-tricalcium phosphate/collagen sponge composite for bone regeneration. Dent Mater J. 2006;25:138–44.

Sigurdsson TJ, Nguyen S, Wikesjo UM. Alveolar ridge augmentation with rhBMP-2 and bone-to-implant contact in induced bone. Int J Periodontics Restorative Dent. 2001;21:461–73.

Chi SH, Kim CK, Cho KS, Huh JS, Sorensen RG, Wozney JM, et al. Effect of recombinant human morphogenetic protein-2/Absorbable Collagen Sponge on healing in 3-wall intrabony defect in dogs. J periodontol. 2002;73:63–72.

Barboza EP, Caula AL, de Oliveria Caula F, de Souza RO, Neto LG, Sorensen RG, et al. Effect of recombinant human morphogenetic protein-2 in an Absorbable Collagen Sponge with space-providing biomaterials on the augmentation of chronic alveolar ridge defect. J Periodontol. 2004;75:702–8.